Search results
Results from the WOW.Com Content Network
He was born in Xinhua County, Loudi City, Hunan, in 1984. [10]He Jiankui attended the University of Science and Technology of China for undergraduate studies from 2002 to 2006, and graduated with a major in modern physics in 2006. [10]
The He Jiankui genome editing incident is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018.
He eventually received widespread international condemnation. He Jiankui, working at the Southern University of Science and Technology (SUSTech) in Shenzhen, China, started a project to help people with HIV-related fertility problems, specifically involving HIV-positive fathers and HIV-negative mothers.
He Jiankui, the Chinese scientist who sparked global outrage in 2018 when he revealed that he had created the first gene-edited children, has put forward a new proposal for modifying human embryos ...
Make People Better is a 2022 documentary film about the use of genetic engineering (called CRISPR gene editing) to enhance two twins girls to be immune to HIV.Directed by Cody Sheehy of Rhumbline Media, it was originated by Samira Kiani, a biotechnologist then at Arizona State University. [1]
The disappearance of tennis star Peng Shuai in China following her accusation of sexual assault against a former top Communist Party official has shined a spotlight on similar cases involving ...
Musunuru is the author of The CRISPR Generation: The Story of the World's First Gene-Edited Babies, in which he delves into the scientific breakthroughs that enabled He Jiankui to create the world's first gene-edited babies, a scandal Musunuru describes as a "historic ethical fiasco, a deeply flawed experiment".
The creation of HIV-resistant babies by Chinese researcher He Jiankui is perhaps the most famous example of gene disruption using this method. [68] It is far less effective at gene correction. Methods of base editing are under development in which a “nuclease-dead” Cas 9 endonuclease or a related enzyme is used for gene targeting while a ...